SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limitedverified

SYMQY

Price:

$0.5579

Market Cap:

$3.86B

SymBio Pharmaceuticals Limited, a Japanese company founded in 2005 and headquartered in Tokyo, specializes in the research, development, manufacturing, and commercialization of pharmaceutical products primarily for oncology and hematology. A significant part of its portfolio is the anticancer agent Treakisym SyB L-0501. Marketed as TREAKISYM, this drug is utilized in treating non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Furthermore, it is currently in Phase III clinical trials for the treatment of relapsed/refractory diffuse large B-cell lymphoma. SymBio is also advancing the development of SyB L-1701, available as a ready-to-dilute formulation, and SyB L-1702,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-08-05

Stock Exchange

OTC

Ticker

SYMQY

The ROE as of June 2026 (TTM) for SymBio Pharmaceuticals Limited (SYMQY) is -424.34%

According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -424.34%. This represents a change of 35.97% compared to the average of -312.09% of the last 4 quarters.

SymBio Pharmaceuticals Limited (SYMQY) Historical ROE (quarterly & annually)

How has SYMQY ROE performed in the past?

The mean historical ROE of SymBio Pharmaceuticals Limited over the last ten years is -85.84%. The current -424.34% ROE has changed 394.32% with respect to the historical average. Over the past ten years (40 quarters), SYMQY's ROE was at its highest in in the December 2021 quarter at 25.31%. The ROE was at its lowest in in the March 2026 quarter at -1036.48%.

Quarterly (TTM)
Annual

Average

-85.84%

Median

-71.99%

Minimum

-375.48%

Maximum

30.13%

SymBio Pharmaceuticals Limited (SYMQY) ROE by Quarter and Year

Discovering the peaks and valleys of SymBio Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 311.14%

Maximum Annual ROE = 30.13%

Minimum Annual Increase = -296.37%

Minimum Annual ROE = -375.48%

Quarterly (TTM)
Annual
YearROEChange
2025-375.48%311.14%
2024-91.33%235.46%
2023-27.22%-296.37%
202213.86%-53.98%
202130.13%-134.30%
2020-87.82%-11.70%
2019-99.46%77.12%
2018-56.15%-54.27%
2017-122.80%191.16%
2016-42.17%-28.99%

SymBio Pharmaceuticals Limited (SYMQY) Average ROE

How has SYMQY ROE performed in the past?

The current ROE of SymBio Pharmaceuticals Limited (SYMQY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-164.68%

5-year avg

-90.01%

10-year avg

-85.84%

SymBio Pharmaceuticals Limited (SYMQY) ROE vs. Peers

How is SYMQY’s ROE compared to its peers?

SymBio Pharmaceuticals Limited’s ROE is greater than Goodness Growth Holdings, Inc. (-69.37%), greater than Ecofibre Limited (-77.39%), less than Elegance Optical International Holdings Limited (183.79%), less than Biocartis Group N.V. (203.74%), less than Kiaro Holdings Corp. (0%), greater than Herantis Pharma Oyj (-21354.84%), greater than Karolinska Development AB (publ) (-19.50%), less than Taihe Group, Inc. (0.81%), greater than INNOCAN PHARMA Corp (-31.76%), less than Oncopeptides AB (publ) (2.08%),

Build a custom stock screener for SymBio Pharmaceuticals Limited (SYMQY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SymBio Pharmaceuticals Limited (SYMQY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is SymBio Pharmaceuticals Limited's ROE?

How is the ROE calculated for SymBio Pharmaceuticals Limited (SYMQY)?

What is the highest ROE for SymBio Pharmaceuticals Limited (SYMQY)?

What is the 3-year average ROE for SymBio Pharmaceuticals Limited (SYMQY)?

What is the 5-year average ROE for SymBio Pharmaceuticals Limited (SYMQY)?

How does the current ROE for SymBio Pharmaceuticals Limited (SYMQY) compare to its historical average?